![](https://www.drivechangemc.org.au/wp-content/uploads/2021/01/dr-alistair-vickery-emerald-clinics.png)
Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.